Who owns ZIOPHARM Oncology?

Key details on ZIOPHARM Oncology (Ticker: ZIOP)

Who owns ZIOPHARM Oncology?

Is ZIOP a good stock to own? Find out who bought ZIOPHARM Oncology, who sold ZIOPHARM Oncology (ZIOP) stock, and who holds a large position in ZIOPHARM Oncology.

Fund Name Number of Shares Share Valuation As Of
Third Security 17.82M $47.03M Sept. 30, 2014
STATE STREET CORPORATION 3.24M $8.57M Sept. 30, 2014
FMR 3.13M $8.28M Sept. 30, 2014
Essex Woodlands Health Ventures 2.76M $10.26M June 30, 2014
MSDC Management 2.75M $7.26M Sept. 30, 2014
Vanguard 2.69M $7.10M Sept. 30, 2014
Belmont Global Advisors 2.27M $10.40M March 31, 2014
BlackRock Fund Advisors 1.97M $5.19M Sept. 30, 2014
SUSQUEHANNA INTERNATIONAL 1.84M $4.86M Sept. 30, 2014
Jennison Associates 1.52M $4.01M Sept. 30, 2014
MORGAN STANLEY 1.27M $3.35M Sept. 30, 2014
Barclays 1.04M $4.15M March 31, 2014
BlackRock Institutional Trust Company, N.A. 981120 $2.59M Sept. 30, 2014
NORTHERN TRUST 928099 $2.45M Sept. 30, 2014
S.A.C. Capital Advisors 888000 $1.86M June 30, 2013
Visium Asset Management 827500 $3.44M Dec. 31, 2012
Ayer Capital Management 809009 $4.41M Sept. 30, 2012
Austin W. Marxe and David M. Greenhouse 776741 $3.23M Dec. 31, 2012
Inves 722342 $3.31M March 31, 2014
GROUP ONE TRADING 617836 $2.49M June 30, 2014
Royce & Associates 576000 $2.28M Sept. 30, 2013
Oxford Asset Management 568669 $3.07M March 31, 2012
Geode Capital Management 535039 $2.16M June 30, 2014
Perceptive Advisors 500000 $2.08M Dec. 31, 2012
Jefferies 486000 $2.89M June 30, 2012

Who sold ZIOPHARM Oncology?

Fund Name Date Sold Number of Shares Sold Share Valuation
UBS AG Dec. 31, 2013 457325 $1.98M
QVT Financial Sept. 30, 2011 936952 $4.13M
Baker Bros. Advisors Sept. 30, 2011 849500 $3.75M
Wells Fargo & Company Sept. 30, 2011 452960 $2.00M
Driehaus Capital Management June 30, 2011 550054 $3.37M
Sunrise Partners Limited Partnership Dec. 31, 2010 1.21M $5.66M
Redmile Dec. 31, 2010 450000 $2.10M